Darya-Varia Laboratoria Tbk (DVLA)

Jakarta
2,400
0(0.00%)
  • Volume:
    32,800
  • Bid/Ask:
    2,400/2,410
  • Day's Range:
    2,400 - 2,450

DVLA Overview

Prev. Close
2,400
Day's Range
2,400-2,450
Revenue
1.9T
Open
2,400
52 wk Range
2,250-3,400
EPS
131
Volume
32,800
Market Cap
2.69T
Dividend (Yield)
39.00
(4.67%)
Average Vol. (3m)
32,743
P/E Ratio
18.32
Beta
0.12
1-Year Change
4.8%
Shares Outstanding
1,120,000,000
Next Earnings Date
May 23, 2022
What is your sentiment on Darya-Varia?
or
Market is currently closed. Voting is open during market hours.

Darya-Varia Laboratoria Tbk News

Darya-Varia Laboratoria Tbk Company Profile

Darya-Varia Laboratoria Tbk Company Profile

Employees
1232
Market
Indonesia

PT Darya-Varia Laboratoria Tbk (Darya-Varia) is an Indonesia-based company operating in the pharmaceutical industry. The Company's major business activities are classified into three business segments: Prescription drugs, Consumer health products and Export and toll manufacturing services. Darya-Varia's leading products under the Prescription drugs segment are namely Mediamer B6 and Obimin - AF, drugs under woman health segment; Thrombo Aspilets, a cardiac medication, and Trifluoperazine, a central nervous system agent. Its products under the Consumer health products segment include Enervon-C, a health supplement and Decolgen FX Tablet, a flu treatment medicine. Other products of the Company include medicated plasters, lotions and creams.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellNeutral
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellSell